Central Pharmaceuticals Ltd. announcements
203 Dhaka Stock Exchange announcements for Central Pharmaceuticals Ltd. (CENTRALPHL) since 2013: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2017 (17).
- Basis for Qualified Opinion
(Basis for Qualified Opinion): The auditor of the company has given the following 'Basis for Qualified Opinion' paragraph in the audit report of the company prepared for the year ended on 30 June 2017. Basis for Qualified Opinion: 1. Provision for interest on Short Term Loan was not made in the accounts. 2. Long-term loan has not been properly segregated into current portion and long-term portion, as a result Current Liabilities and Non-Current Liabilities (cont.) (Continuation news of CENTRALPHL): not properly reflected in the Financial Statement3. Provision for Bad debt was not made in the accounts. 4. Advance Tax Tk.227,976,980 and Liabilities for Tax Tk.243,038,359 remain unadjusted in the accounts as a result gross Assets and gross liabilities are overstated. 5. The Bank Accounts of the company was frozen by the Tax Authority, as a result all the transactions both revenue and expenditure were made through cash. (end)
- Resumption after record date
Trading of the shares of the Company will resume on 03.12.2017 after record date.
- Suspension for Record Date
Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2017.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 28.11.2017 to 29.11.2017. Trading of the shares of the Company will remain suspended on record date i.e., 30.11.2017.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.14 for July-September, 2017 as against Tk. 0.13 for July-September, 2016; NOCFPS was Tk. 0.02 for July-September, 2017 as against Tk. 0.01 for July-September, 2016. NAV per share was Tk. 16.93 as on September 30, 2017 and Tk. 16.78 as on June 30, 2017.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2017 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.
- Cancellation of MOU with Alif Group
Referring to their earlier news (disseminated by DSE on 22.02.2017) regarding signing a MOU with Alif Group, The Company has further informed the following: "Earlier on 20.02.2017 the Board of Directors of the Company decided to sell their individual respective holdings shares separately to different Directors and concern of Alif Group. But due to long time delay by Alif Group both parties mutually agreed to cancel the same MOU ".
- Dividend Declaration
The Board of Directors has recommended 10% stock dividend for the year ended on June 30, 2017. Date of AGM: 27.12.2017, Time of AGM: 11:30 AM, Venue: HALL PATIO, Gulshan Club Ltd., House # NWJ/2/A, Bir Uttom Sultan Mahmud Road (Old 50), Gulshan-2 Dhaka. Record date: 30.11.2017. The Company has also reported EPS of Tk. 1.05, NAV per share of Tk. 16.78 and NOCFPS of Tk. 0.19 for the year ended on June 30, 2017 as against EPS of Tk. 1.05 for the year ended on June 30, 2016.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2017) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2017 at 2:45 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.36 for January-March, 2017 as against Tk. 0.20 for January-March, 2016; EPS was Tk. 1 .09 for July, 2016-March, 2017 as against Tk. 0.75 for July, 2015-March, 2016. NOCFPS was Tk. 0.13 for July, 2016-March, 2017 as against Tk. 0.06 for July, 2015-March, 2016. NAV per share was Tk. 16.82 as of March 31, 2017 and Tk. 15.73 as of June 30, 2016.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.
- Regarding closure of Production
In connection with the instruction for closure of production and distribution of Penicillin, Cephalosporin, Steroid, and cancer antidote of 28 medicine companies within next 3 days, the Company informed the following: As necessary set up for manufacturing of Penicillin and Cephalosporin type medicine was not completed, Drugs Administrative Authority suspended the manufacturing of stated medicine (Ref. No. DA/ML-060/05/2341 dated 20.02.2012) and since then the company is not manufacturing any type of Penicillin, Cephalosporin medicine in its factory. Moreover the Company did not take permission from Drug Administrative Authority for production of Steroid and cancer antidote medicine. As a result of that honorable shareholders and other well wishers of the company do not have any reasonable ground to be confused and in panic. This instruction will have no impact on production of the company. So there is no scope of misunderstanding regarding this.
- Signing MOU with Alif Group to sell all 5 existing Directors' share
The Company has informed that the Board of Directors has decided to sign a MOU with Alif Group that all existing 5 Directors of Central Pharmaceuticals Ltd. will individually and separately sell their respective shares gradually to different Directors/concerns of Alif Group through Block market. After sale of shares by existing Directors of the Company through Block market, the Directors/concerns of Alif Group will form new Board and appoint new Chairman and Managing Director accordingly.
- Q2 Financials
EPS was Tk. 0.61 for Oct.-December, 2016 as against Tk. 0.28 for Oct.-December, 2015; EPS was Tk. 0.73 for July-December, 2016 as against Tk. 0.55 for July-December, 2015. NOCFPS was Tk. 0.10 for July-December, 2016 as against Tk. 0.07 for July-December, 2015. NAV per share was Tk. 16.46 as of December 31, 2016 and Tk. 15.73 as of June 30, 2016.
- Reschedule of Board Meeting schedule under LR 16(1)
The Company has further informed that the meeting under LR 16(1) will now be held on January 25, 2017 at 3:00 PM instead of January 23, 2017 to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.
- Board Meeting
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 23, 2017 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.